(Total Views: 902)
Posted On: 06/28/2020 12:04:06 PM
Post# of 154975
The article you cited doesn't say anything about kinase inhibitors. It does help make a case for leronlimab.
Quote:
Gene Ontology analysis of differentially expressed genes indicated changes in a number of pathways, including leukocyte activation and pro-inflammatory cytokine secretion. Immune cell dysregulation may therefore be at least partially responsible for the differences in morbidity and mortality during infection with the PB1-UFOΔ or PB1-UFOSYN viruses.
(1)
(0)
